| Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting LI Sánchez-Abarca, S Gutierrez-Cosio, C Santamaría, ... Blood, The Journal of the American Society of Hematology 115 (1), 107-121, 2010 | 242 | 2010 |
| Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease F Sánchez-Guijo, T Caballero-Velázquez, O López-Villar, A Redondo, ... Biology of Blood and Marrow Transplantation 20 (10), 1580-1585, 2014 | 127 | 2014 |
| Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study V Escamilla Gómez, V García-Gutiérrez, L López Corral, ... Bone marrow transplantation 55 (3), 641-648, 2020 | 78 | 2020 |
| Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population B Blanco, JA Pérez-Simón, LI Sánchez-Abarca, T Caballero-Velazquez, ... haematologica 94 (7), 975, 2009 | 72 | 2009 |
| Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma B Paiva, M Chandia, MB Vidriales, E Colado, T Caballero-Velázquez, ... Blood, The Journal of the American Society of Hematology 124 (8), 1300-1303, 2014 | 67 | 2014 |
| Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post‐allogeneic transplantation for high‐risk myeloma patients T Caballero‐Velázquez, L López‐Corral, C Encinas, C Castilla‐Llorente, ... British journal of haematology 162 (4), 474-482, 2013 | 44 | 2013 |
| Immunomodulatory effect of vitamin D after allogeneic stem cell transplantation: results of a prospective multicenter clinical trial T Caballero-Velázquez, I Montero, F Sánchez-Guijo, R Parody, ... Clinical Cancer Research 22 (23), 5673-5681, 2016 | 43 | 2016 |
| Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens B Blanco, LI Sánchez-Abarca, T Caballero-Velázquez, C Santamaría, ... Leukemia research 35 (10), 1412-1415, 2011 | 37 | 2011 |
| Sensitivity of hematopoietic stem cells to mitochondrial dysfunction by SdhD gene deletion JA Bejarano-García, Á Millán-Uclés, IV Rosado, LI Sánchez-Abarca, ... Cell Death & Disease 7 (12), e2516-e2516, 2016 | 35 | 2016 |
| Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia B Paiva, MB Vidriales, A Sempere, F Tarín, E Colado, C Benavente, ... Leukemia 35 (8), 2358-2370, 2021 | 32 | 2021 |
| Limbus damage in ocular graft-versus-host disease RL Pérez, JA Pérez-Simón, T Caballero-Velazquez, T Flores, S Carrancio, ... Biology of Blood and Marrow Transplantation 17 (2), 270-273, 2011 | 31 | 2011 |
| Cannabinoid derivatives exert a potent anti‐myeloma activity both in vitro and in vivo MV Barbado, M Medrano, T Caballero‐Velázquez, I Álvarez‐Laderas, ... International Journal of Cancer 140 (3), 674-685, 2017 | 28 | 2017 |
| Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment S Gutierrez-Cosio, L de la Rica, E Ballestar, C Santamaría, ... Leukemia research 36 (7), 895-899, 2012 | 28 | 2012 |
| Effect of vitamin D treatment in chronic GVHD F Silva, JA Pérez-Simón, T Caballero-Velázquez, FM Sánchez-Guijo, ... Bone marrow transplantation 46 (10), 1395-1397, 2011 | 27 | 2011 |
| The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation T Caballero-Velázquez, LI Sánchez-Abarca, S Gutierrez-Cosio, B Blanco, ... haematologica 97 (9), 1329, 2012 | 25 | 2012 |
| Human bone marrow stromal cells differentiate into corneal tissue and prevent ocular graft-versus-host disease in mice LI Sánchez-Abarca, E Hernández-Galilea, R Lorenzo, C Herrero, ... Cell transplantation 24 (12), 2423-2433, 2015 | 24 | 2015 |
| Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting G Afram, JAP Simón, M Remberger, T Caballero-Velázquez, R Martino, ... Medical Oncology 35, 1-8, 2018 | 22 | 2018 |
| Evaluation of prognostic factors among patients with chronic graft-versus-host disease JA Pérez-Simón, G Afram, R Martino, JL Piñana, T Caballero-Velazquez, ... haematologica 97 (8), 1187, 2012 | 22 | 2012 |
| Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease FN Villanueva, JA Pérez-Simón, FF Silva, TT Caballero-Velázquez, ... Biology of Blood and Marrow Transplantation 15 (10), 1331-1336, 2009 | 21 | 2009 |
| Uptake and delivery of antigens by mesenchymal stromal cells LI Sánchez-Abarca, I Álvarez-Laderas, MD Campelo, ... Cytotherapy 15 (6), 673-678, 2013 | 19 | 2013 |
